Back to Agenda
FDA’s Biosimilars Access Plan
Speaker(s)
Leah Christl, PHD
Amgen, United States
Exec Director, Global Biosimilars Regulatory Affairs & Regulatory & R&D Policy
Have an account?
Already a DIA Member? Sign in. Not a member? Join.
Sign in
Not a Member?
Novotel London Paddington
Oct 22, 2018 8:00 AM - Oct 23, 2018 3:30 PM
3 Kingdom Street, London, W2 6BD, United Kingdom
Biosimilars Conference
Aligning multi-stakeholder goals to work towards a sustainable future